Literature DB >> 25954104

Prognostic significance of preoperative platelet count in patients with gallbladder cancer.

Rui-Tao Wang1, Ling-Qiang Zhang1, Yi-Ping Mu1, Jian-Bo Li1, Xin-Sen Xu1, Qing Pang1, Lian-Kang Sun1, Xing Zhang1, Shun-Bin Dong1, Lin Wang1, Chang Liu1.   

Abstract

AIM: To investigate the prognostic value of preoperative platelet count (PLT) in patients with primary gallbladder cancer (GBC).
METHODS: The clinical data of 223 GBC patients after surgery was retrospectively reviewed. A receiver operating characteristic (ROC) curve was plotted to verify the optimum cutoff point for PLT. Univariate and multivariate survival analyses were performed to identify the factors associated with the prognosis.
RESULTS: The ROC curve showed that the optimum cutoff point for PLT was 178 × 10(9)/L, and the entire cohort was stratified into group A with PLT > 178 × 10(9)/L and group B with PLT ≤ 178 × 10(9)/L. Group A had a better survival than group B (P < 0.001). There was an obvious difference between the two groups in terms of the differentiation degree, advanced tumor stage, lymph node metastasis (P < 0.001) and pathological type (P < 0.05). The univariate analysis demonstrated that tumor location, differentiation degree, TNM stage, Nevin stage, lymph node metastasis and PLT were associated with overall survival (P < 0.001). In the multivariate analysis, PLT (P = 0.032), lymph node metastasis (P = 0.007), tumor location (P < 0.001) and TNM stage (P = 0.005) were independent prognostic factors.
CONCLUSION: PLT is closely correlated with GBC prognosis and could be used to identify the population with a poorer prognosis after surgery.

Entities:  

Keywords:  Gallbladder cancer; Platelet count; Prognostic factor; Survival

Mesh:

Year:  2015        PMID: 25954104      PMCID: PMC4419071          DOI: 10.3748/wjg.v21.i17.5303

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients.

Authors:  Hee Yeon Seo; Joong Min Park; Kyong Hwa Park; Seok Jin Kim; Sang Cheul Oh; Byung Soo Kim; Yeul Hong Kim; Jun Suk Kim
Journal:  Jpn J Clin Oncol       Date:  2010-07-20       Impact factor: 3.019

2.  Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short survival.

Authors:  Mrinal M Patnaik; Domenica Caramazza; Naseema Gangat; Curtis A Hanson; Animesh Pardanani; Ayalew Tefferi
Journal:  Eur J Haematol       Date:  2009-11-06       Impact factor: 2.997

3.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors:  F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

4.  Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human gallbladder lesions.

Authors:  S Yamamoto; Y Kitadai; A Tsuchida; T Sasaki; K Matsubara; G Kajiyama
Journal:  Eur J Cancer       Date:  2000-01       Impact factor: 9.162

5.  Incorporation of a circulating protein into megakaryocyte and platelet granules.

Authors:  P J Handagama; J N George; M A Shuman; R P McEver; D F Bainton
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas.

Authors:  Kimberly M Brown; Christinnah Domin; Gerard V Aranha; Sherri Yong; Margo Shoup
Journal:  Am J Surg       Date:  2005-03       Impact factor: 2.565

7.  Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival.

Authors:  Sae Byeol Choi; Hyung Joon Han; Chung Yun Kim; Wan Bae Kim; Tae-Jin Song; Sung Ock Suh; Young Chul Kim; Sang Yong Choi
Journal:  Hepatogastroenterology       Date:  2012 Jan-Feb

8.  Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.

Authors:  Maolan Li; Zhou Zhang; Xiaoguang Li; Junyi Ye; Xiangsong Wu; Zhujun Tan; Chang Liu; Baiyong Shen; Xu-An Wang; Wenguang Wu; Daizhan Zhou; Di Zhang; Ting Wang; Bingya Liu; Kai Qu; Qichen Ding; Hao Weng; Qian Ding; Jiasheng Mu; Yijun Shu; Runfa Bao; Yang Cao; Peizhan Chen; Tianyu Liu; Lin Jiang; Yunping Hu; Ping Dong; Jun Gu; Wei Lu; Weibin Shi; Jianhua Lu; Wei Gong; Zhaohui Tang; Yong Zhang; Xuefeng Wang; Y Eugene Chin; Xiaoling Weng; Hong Zhang; Wei Tang; Yonglan Zheng; Lin He; Hui Wang; Yun Liu; Yingbin Liu
Journal:  Nat Genet       Date:  2014-07-06       Impact factor: 38.330

Review 9.  Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer.

Authors:  Deva Sharma; Kathleen E Brummel-Ziedins; Beth A Bouchard; Chris E Holmes
Journal:  J Cell Physiol       Date:  2014-08       Impact factor: 6.384

10.  Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.

Authors:  Myriam Labelle; Shahinoor Begum; Richard O Hynes
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743

View more
  8 in total

1.  Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer.

Authors:  Gábor Rubovszky; Barna Budai; Erna Ganofszky; Zsolt Horváth; Éva Juhos; Balázs Madaras; Tünde Nagy; Eszter Szabó; Tamás Pintér; Erika Tóth; Péter Nagy; István Láng; Erika Hitre
Journal:  Pathol Oncol Res       Date:  2017-04-29       Impact factor: 3.201

2.  Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer.

Authors:  Zichen Bian; Jialin Meng; Qingsong Niu; Xiaoyan Jin; Jinian Wang; Xingliang Feng; Hong Che; Jun Zhou; Li Zhang; Meng Zhang; Chaozhao Liang
Journal:  Cancer Manag Res       Date:  2020-09-15       Impact factor: 3.989

3.  Pretreatment plasma fibrinogen as an independent prognostic indicator of prostate cancer patients treated with androgen deprivation therapy.

Authors:  Y Wang; W Yin; Z Wang; J Huang; J Pan; Y Zhu; F Xu; X Shao; J Sha; Y Cai; Q Liu; B Dong; W Xue; Y Huang
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-03-08       Impact factor: 5.554

4.  Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma.

Authors:  Hang Xu; Jian-Zhong Ai; Ping Tan; Tian-Hai Lin; Xi Jin; Li-Na Gong; Hao-Ran Lei; Lu Yang; Qiang Wei
Journal:  Asian J Androl       Date:  2020 Mar-Apr       Impact factor: 3.285

5.  The clinical significance of preoperative serum fibrinogen levels and platelet counts in patients with gallbladder carcinoma.

Authors:  Peng Cao; Lei Jiang; Liang-Yi Zhou; Yan-Ling Chen
Journal:  BMC Gastroenterol       Date:  2021-10-07       Impact factor: 3.067

6.  Elevated Platelet Distribution Width Predicts Poor Prognosis in Gallbladder Carcinoma.

Authors:  Fei Liu; Hai-Jie Hu; Parbatraj Regmi; Yan-Wen Jin; Wen-Jie Ma; Jun-Ke Wang; Rui-Qi Zou; Fu-Yu Li
Journal:  Cancer Manag Res       Date:  2021-06-10       Impact factor: 3.989

7.  Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.

Authors:  Wei-Yu Xu; Hao-Hai Zhang; Xiao-Bo Yang; Yi Bai; Jian-Zhen Lin; Jun-Yu Long; Jian-Ping Xiong; Jun-Wei Zhang; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2018-04-07       Impact factor: 5.742

8.  Blood prognostic predictors of treatment response for patients with papillary thyroid cancer.

Authors:  Xiangxiang Liu; Zhongke Huang; Xianghui He; Xiangqian Zheng; Qiang Jia; Jian Tan; Yaguang Fan; Cen Lou; Zhaowei Meng
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.